PTSM: Pharmaceutical Technology Sourcing and Management, Jun 2, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
PTSM: Pharmaceutical Technology Sourcing and Management, Jun 2, 2011
APIs
Global Pharma Market Expected to Reach $1 Trillion
By Patricia Van Arnum
The global pharmaceutical market is expected to reach sales of nearly $1.1 trillion by 2015, marked by slowing growth in developed markets and strong sales in emerging markets.
Sourcing
Innovation in Sourcing
By Patricia Van Arnum
Industry experts share perspectives on value creation in sourcing, procurement, and external development and manufacturing.
Outsourcing
Supply Chain Pain
By Jim Miller
Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.
CSR and Sustainability Forum
IFPMA Outlines Global Health Initiatives
By Patricia Van Arnum
Eduardo Pisani, director general of the International Federation of Pharmaceutical Manufacturers & Associations, discusses the global health initiatives and related activities of the association.
WHO Meeting Produces Several Action and Policy Items
By Patricia Van Arnum
The World Health Assembly, the decision-making body of the World Health Organization, met in Geneva last month to discuss and take action on initiatives relating to influenza pandemic preparedness, noncommunicable diseases, and the health-related UN Millennium Development Goals.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here